Note | |
| |
Entity | Sarcoma metastasis |
Note | gp78/AMFR targets KAI1, a known metastasis suppressor protein for ubiquitin mediated proteasomal degradation (Tsai et al., 2007). Thus gp78/AMFR has role in metastasis of human sarcoma. Furthermore, a human sarcoma tissue microarray study documents that tumors with low gp78 expression has higher levels of KAI1 and high gp78 level lower KAI1 expression in tumors (Tsai et al., 2007). |
| |
| |
Entity | Breast cancer |
Note | gp78/AMFR expression in gp78 transgenic mammary glands induces mammary gland hyperplasia, increases duct number and network density and shows down-regulation of KAI1 metastasis suppressor (Joshi et al., 2010). Additionally, gp78/AMFR has been identified as one of the most mutated genes in breast cancer (Sjöblom et al., 2006). Consistently, gp78/AMFR is overexpressed in human breast cancer and is negatively associated with patients' clinical outcome (Jiang et al., 2006). |
| |
| |
Entity | Gastric carcinoma |
Note | gp78/AMFR expression may be associated with the progression and invasion of gastric carcinoma as well as the prognoses of the patients (Hirono et al., 1996). Furthermore, by using same 3F3A antibody it was reported that gp78/AMFR expression is associated with lymph node metastasis and peritoneal dissemination in gastric carcinoma (Taniguchi et al., 1998). |
| |
| |
Entity | Colorectal cancer |
Note | gp78/AMFR expression is correlated high incidence of recurrence of the patients with colorectal cancer (Nakamori et al., 1994). |
| |
| |
Entity | Melanoma |
Note | It was showed by using 3F3A antibody that gp78/AMFR protein expression in human melanoma cell lines correlates to their metastatic potential. While in thin tumors weak/heterogenous gp78/AMFR expression predominated, in thick tumors the strong gp78/AMFR expression profile was predominant (Tímár et al., 2002). |
| |
| |
Entity | Lung cancer |
Note | Using immunohistochemical staining the gp78/AMFR expression was showed to be associated with histologic type of tumor, mainly in adenocarcinoma (Kara et al., 2001). |
| |
| |
Entity | Hepatocellular carcinoma |
Note | The expression of gp78/AMFR significantly increased in hepatocellular carcinoma compared with pericarcinomatous liver tissues. Furthermore, there is a strong correlation between AMFR expression and invasion and metastasis of HCC (Wang et al., 2007). |
| |
| |
Entity | Bladder carcinoma |
Note | While in normal urothelium gp78/AMFR is not expressed, its expression is increased in bladder carcinoma specimens (Otto et al., 1994). |
| |
| |
Entity | Cardiovascular diseases and hypercholesterolemia |
Note | Accumulation of sterols in ER membranes triggers the binding of HMG CoA reductase, the rate limiting enzyme of cholesterol biosynthesis, to the Insig1-gp78/AMFR complex which is essential for the ubiquitination and proteasomal degradation of HMGCoA-reductase (Goldstein et al., 2006; Jo and DeBose-Boyd, 2010). gp78/AMFR is also the E3 ligase of apolipoprotein B100, the protein component of atherogenic lipoproteins, overproduction of which is a common feature of human dyslipidemia (Liang et al., 2003). |
| |
| |
Entity | Cystic fibrosis |
Note | gp78/AMFR degrades mutant cystic fibrosis transmembrane conductance regulator (CFTRΔF508) associated with cystic fibrosis (Ballar et al., 2010; Morito et al., 2008). |
| |
| |
Entity | Metabolism and disposition of drugs |
Note | gp78/AMFR participates in proteasomal degradation of CYP3A4, a dominant human liver cytochrome P450 enzyme functioning in the metabolism and disposition of drugs and responsible for many adverse drug-drug interactions (Kim et al., 2010; Pabarcus et al., 2009). |
| |
| |
Entity | Chronic obstructive pulmonary disease |
Note | gp78/AMFR expression is increased with the severity of emphysema (Min et al., 2011). |
| |
| |
Entity | Neurodegenerative diseases |
Note | gp78/AMFR may play a protective role against mutant huntingtin toxicity. Mutant huntingtin hinders polyubiquitin binding to the cue domain of gp78/AMFR and causes aggregation of ligase (Yang et al., 2010). gp78/AMFR also enhances ubiquitination, degradation, suppression of aggregation of mutant SOD1 associated with amyotrophic lateral sclerosis (ALS), and mutant ataxin-3 associated with Machado-Joseph disease. Furthermore, in spinal cords of ALS mice, gp78/AMFR expression is significantly is up-regulated (Ying et al., 2009). |
| |
| |
Entity | Alpha-1-antitrypsin deficiency |
Note | gp78/AMFR targets mutant ATZ (Z-variant alpha-1-antitrypsin) associated with alpha-1-antitrypsin deficiency for the proteasomal degradation and increases its solubility (Shen et al., 2006). |
| |
Differential regulation of CFTRDeltaF508 degradation by ubiquitin ligases gp78 and Hrd1. |
Ballar P, Ors AU, Yang H, Fang S. |
Int J Biochem Cell Biol. 2010 Jan;42(1):167-73. Epub 2009 Oct 12. |
PMID 19828134 |
|
The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation. |
Ballar P, Shen Y, Yang H, Fang S. |
J Biol Chem. 2006 Nov 17;281(46):35359-68. Epub 2006 Sep 20. |
PMID 16987818 |
|
Ufd1 is a cofactor of gp78 and plays a key role in cholesterol metabolism by regulating the stability of HMG-CoA reductase. |
Cao J, Wang J, Qi W, Miao HH, Wang J, Ge L, DeBose-Boyd RA, Tang JJ, Li BL, Song BL. |
Cell Metab. 2007 Aug;6(2):115-28. |
PMID 17681147 |
|
The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site. |
Chen B, Mariano J, Tsai YC, Chan AH, Cohen M, Weissman AM. |
Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):341-6. Epub 2006 Jan 3. |
PMID 16407162 |
|
Autocrine motility factor receptor: a clinical review. |
Chiu CG, St-Pierre P, Nabi IR, Wiseman SM. |
Expert Rev Anticancer Ther. 2008 Feb;8(2):207-17. (REVIEW) |
PMID 18279062 |
|
The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. |
Fang S, Ferrone M, Yang C, Jensen JP, Tiwari S, Weissman AM. |
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14422-7. Epub 2001 Nov 27. |
PMID 11724934 |
|
Protein sensors for membrane sterols. |
Goldstein JL, DeBose-Boyd RA, Brown MS. |
Cell. 2006 Jan 13;124(1):35-46. (REVIEW) |
PMID 16413480 |
|
Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. |
Hirono Y, Fushida S, Yonemura Y, Yamamoto H, Watanabe H, Raz A. |
Br J Cancer. 1996 Dec;74(12):2003-7. |
PMID 8980404 |
|
Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer. |
Jiang WG, Raz A, Douglas-Jones A, Mansel RE. |
J Histochem Cytochem. 2006 Feb;54(2):231-41. Epub 2005 Oct 3. |
PMID 16204225 |
|
Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase. |
Jo Y, Debose-Boyd RA. |
Crit Rev Biochem Mol Biol. 2010 Jun;45(3):185-98. (REVIEW) |
PMID 20482385 |
|
A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase. |
Joshi B, Li L, Nabi IR. |
J Biol Chem. 2010 Mar 19;285(12):8830-9. Epub 2010 Jan 20. |
PMID 20089858 |
|
Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer. |
Kara M, Ohta Y, Tanaka Y, Oda M, Watanabe Y. |
Ann Thorac Surg. 2001 Mar;71(3):944-8. |
PMID 11269478 |
|
Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance. |
Kim SM, Acharya P, Engel JC, Correia MA. |
J Biol Chem. 2010 Nov 12;285(46):35866-77. Epub 2010 Sep 6. |
PMID 20819951 |
|
Multiple modes of interaction of the deglycosylation enzyme, mouse peptide N-glycanase, with the proteasome. |
Li G, Zhou X, Zhao G, Schindelin H, Lennarz WJ. |
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15809-14. Epub 2005 Oct 25. |
PMID 16249333 |
|
Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells. |
Liang JS, Kim T, Fang S, Yamaguchi J, Weissman AM, Fisher EA, Ginsberg HN. |
J Biol Chem. 2003 Jun 27;278(26):23984-8. Epub 2003 Apr 1. |
PMID 12670940 |
|
Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysema. |
Min T, Bodas M, Mazur S, Vij N. |
J Mol Med (Berl). 2011 Jun;89(6):577-93. Epub 2011 Feb 12. |
PMID 21318260 |
|
Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508. |
Morito D, Hirao K, Oda Y, Hosokawa N, Tokunaga F, Cyr DM, Tanaka K, Iwai K, Nagata K. |
Mol Biol Cell. 2008 Apr;19(4):1328-36. Epub 2008 Jan 23. |
PMID 18216283 |
|
Cell shape modulation alters glycosylation of a metastatic melanoma cell-surface antigen. |
Nabi IR, Raz A. |
Int J Cancer. 1987 Sep 15;40(3):396-402. |
PMID 3623718 |
|
Identification of B16-F1 melanoma autocrine motility-like factor receptor. |
Nabi IR, Watanabe H, Raz A. |
Cancer Res. 1990 Jan 15;50(2):409-14. |
PMID 2153051 |
|
Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. |
Nakamori S, Watanabe H, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Raz A. |
Cancer. 1994 Oct 1;74(7):1855-62. |
PMID 8082090 |
|
Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. |
Otto T, Birchmeier W, Schmidt U, Hinke A, Schipper J, Rubben H, Raz A. |
Cancer Res. 1994 Jun 15;54(12):3120-3. |
PMID 8205527 |
|
CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases. |
Pabarcus MK, Hoe N, Sadeghi S, Patterson C, Wiertz E, Correia MA. |
Arch Biochem Biophys. 2009 Mar 1;483(1):66-74. Epub 2008 Dec 10. |
PMID 19103148 |
|
Proteins of the endoplasmic-reticulum-associated degradation pathway: domain detection and function prediction. |
Ponting CP. |
Biochem J. 2000 Oct 15;351 Pt 2:527-35. |
PMID 11023840 |
|
Ubiquitin ligase gp78 increases solubility and facilitates degradation of the Z variant of alpha-1-antitrypsin. |
Shen Y, Ballar P, Fang S. |
Biochem Biophys Res Commun. 2006 Nov 3;349(4):1285-93. Epub 2006 Sep 7. |
PMID 16979136 |
|
The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. |
Shimizu K, Tani M, Watanabe H, Nagamachi Y, Niinaka Y, Shiroishi T, Ohwada S, Raz A, Yokota J. |
FEBS Lett. 1999 Aug 6;456(2):295-300. |
PMID 10456327 |
|
Autocrine motility factor is a growth factor. |
Silletti S, Raz A. |
Biochem Biophys Res Commun. 1993 Jul 15;194(1):446-57. |
PMID 8392842 |
|
The consensus coding sequences of human breast and colorectal cancers. |
Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. |
Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. |
PMID 16959974 |
|
Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. |
Song BL, Sever N, DeBose-Boyd RA. |
Mol Cell. 2005 Sep 16;19(6):829-40. |
PMID 16168377 |
|
The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. |
Taniguchi K, Yonemura Y, Nojima N, Hirono Y, Fushida S, Fujimura T, Miwa K, Endo Y, Yamamoto H, Watanabe H. |
Cancer. 1998 Jun 1;82(11):2112-22. |
PMID 9610690 |
|
Expression and function of the AMF receptor by human melanoma in experimental and clinical systems. |
Timar J, Raso E, Dome B, Ladanyi A, Banfalvi T, Gilde K, Raz A. |
Clin Exp Metastasis. 2002;19(3):225-32. |
PMID 12067203 |
|
The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. |
Tsai YC, Mendoza A, Mariano JM, Zhou M, Kostova Z, Chen B, Veenstra T, Hewitt SM, Helman LJ, Khanna C, Weissman AM. |
Nat Med. 2007 Dec;13(12):1504-9. Epub 2007 Nov 25. |
PMID 18037895 |
|
Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma. |
Wang W, Yang LY, Yang ZL, Peng JX, Yang JQ. |
Dig Dis Sci. 2007 Mar;52(3):770-5. |
PMID 17265125 |
|
Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. |
Watanabe H, Carmi P, Hogan V, Raz T, Silletti S, Nabi IR, Raz A. |
J Biol Chem. 1991 Jul 15;266(20):13442-8. |
PMID 1649192 |
|
Huntingtin interacts with the cue domain of gp78 and inhibits gp78 binding to ubiquitin and p97/VCP. |
Yang H, Liu C, Zhong Y, Luo S, Monteiro MJ, Fang S. |
PLoS One. 2010 Jan 26;5(1):e8905. |
PMID 20126661 |
|
Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. |
Ying Z, Wang H, Fan H, Zhu X, Zhou J, Fei E, Wang G. |
Hum Mol Genet. 2009 Nov 15;18(22):4268-81. Epub 2009 Aug 6. |
PMID 19661182 |
|